Seroatlas · Human Serome Atlas

LGSN

Lengsin

Also known as: GLULD1, LGS, LGSN_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5TDP6
Gene
LGSN
Ensembl
ENSG00000146166
Chromosome
6
Canonical length
509 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm,Vesicles

OverviewNCBI Gene

This gene encodes a protein with similarity to the GS I members of the glutamine synthetase superfamily. The encoded protein is referred to as a pseudo-glutamine synthetase because it has no glutamine synthesis activity and may function as a chaperone protein. This protein is localized to the lens and may be associated with cataract disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]

Canonical amino-acid sequenceUniProt

509 residues, UniProt reviewed canonical sequence.

>Q5TDP6|LGSN
     1  MNNEEDLLQE DSTRDEGNET EANSMNTLRR TRKKVTKPYV CSTEVGETDM SNSNDCMRDS
    61  SQILTPPQLS SRMKHIRQAM AKNRLQFVRF EATDLHGVSR SKTIPAHFFQ EKVSHGVCMP
   121  RGYLEVIPNP KDNEMNNIRA TCFNSDIVLM PELSTFRVLP WADRTARVIC DTFTVTGEPL
   181  LTSPRYIAKR QLSHLQASGF SLLSAFIYDF CIFGVPEILN SKIISFPALT FLNNHDQPFM
   241  QELVDGLYHT GANVESFSSS TRPGQMEISF LPEFGISSAD NAFTLRTGVK EVARKYNYIA
   301  SFFIETGFCD SGILSHSLWD VDRKKNMFCS TSGTEQLTIT GKKWLAGLLK HSAALSCLMA
   361  PSVSCRKRYS KDRKDLKKSV PTTWGYNDNS CIFNIKCHGE KGTRIENKLG SATANPYLVL
   421  AATVAAGLDG LHSSNEVLAG PDESTDFYQV EPSEIPLKLE DALVALEEDQ CLRQALGETF
   481  IRYFVAMKKY ELENEEIAAE RNKFLEYFI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against LGSN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
3.5 nTPM

Expression across tissuesHPA

Tissue

  • liver: 3.5 nTPM
  • kidney: 1.8 nTPM
  • placenta: 1 nTPM
  • spinal cord: 0.4 nTPM
  • testis: 0.3 nTPM
  • bone marrow: 0.2 nTPM

Single-cell type

  • respiratory ciliated cells: 30 nCPM
  • proximal tubule cells: 13 nCPM
  • parietal cells: 12 nCPM
  • late spermatids: 6.2 nCPM
  • endometrial ciliated cells: 6 nCPM
  • transitional alveolar cells: 5.5 nCPM

Immune cell

  • basophil: 0.5 nTPM
  • neutrophil: 0.3 nTPM
  • plasmacytoid DC: 0.2 nTPM
  • memory B-cell: 0.1 nTPM
  • naive CD8 T-cell: 0.1 nTPM
  • classical monocyte: 0 nTPM

Brain region

  • cerebellum: 1.9 nTPM
  • white matter: 1.9 nTPM
  • medulla oblongata: 1.7 nTPM
  • pons: 1.5 nTPM
  • basal ganglia: 1.4 nTPM
  • cerebral cortex: 1.4 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about LGSN.

Disease | ImmuneIEDB

Conditions an epitope on LGSN was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.56
gnomAD pLI
0
gnomAD missense Z
-0.55
DepMap mean gene effect
-0.04
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

InteractionsUniProt · HPA

Protein binding partners of LGSN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads LGSN as an antibody target. Whether an autoantibody or antibody against LGSN could matter depends on whether native LGSN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

LGSN is annotated at the cell surface, where native LGSN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label LGSN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/LGSN. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...